Open AccessRandomized clinical trial of extensive intraoperative peritoneal lavage versus standard treatment for resectable advanced gastric cancer (CCOG 1102 trial)
Author(s) -
Misawa K.,
Mochizuki Y.,
Sakai M.,
Teramoto H.,
Morimoto D.,
Nakayama H.,
Tanaka N.,
Matsui T.,
Ito Y.,
Ito S.,
Tanaka K.,
Uemura K.,
Morita S.,
Kodera Y.
Publication year - 2019
Publication title -
british journal of surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.202
H-Index - 201
eISSN - 1365-2168
pISSN - 0007-1323
DOI - 10.1002/bjs.11303
Subject(s) - medicine , hazard ratio , randomized controlled trial , clinical endpoint , surgery , gastrectomy , cancer , survival rate , incidence (geometry) , adverse effect , gastroenterology , confidence interval , physics , optics
A survival benefit of extensive intraoperative peritoneal lavage (EIPL) has been reported in patients with gastric cancer with positive peritoneal cytology. The hypothesis of this study was that EIPL may reduce peritoneal recurrence in patients with advanced gastric cancer who undergo surgery with curative intent.